US92556V1061 - Common Stock
VIATRIS INC
NASDAQ:VTRS (12/24/2024, 7:44:57 PM)
After market: 12.4 0 (0%)12.4
-0.09 (-0.72%)
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. The company is headquartered in Canonsburg, Pennsylvania and currently employs 38,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The firm operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.
VIATRIS INC
1000 Mylan Boulevard
Canonsburg PENNSYLVANIA 15317
P: 17245141800
CEO: Michael Goettler
Employees: 33000
Website: https://www.viatris.com/en
Curious about the market action on Tuesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in...
Top movers analysis in the middle of the day of S&P500 on 2024-12-12: top gainers and losers in today's session.
Here you can normally see the latest stock twits on VTRS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: